首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 美国FDA药品数据库(本栏目更新到2026-3-31)
药品名称:
商品名称:
药品NDC:
上市日期:
-
格式:2020-5-3
注册申请号:
市场分类:
不限
OTC MONOGRAPH NOT FINAL
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
ANDA
BLA
NDA AUTHORIZED GENERIC
NDA
UNAPPROVED MEDICAL GAS
OTC MONOGRAPH FINAL
UNAPPROVED HOMEOPATHIC
UNAPPROVED DRUG OTHER
活性成分:
持证企业:
美国药品NDC(国家药品编码)与药品说明书数据库
美国NDC未完成药物数据库文件
美国NDC复合药物数据库文件
美国NDC 数据库排除药物数据库文件
 美国药品NDC(国家药品编码)与药品说明书数据库112362条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
nivolumab and hyaluronidase-nvhy
OPDIVO QVANTIG
0003-6120
E.R. Squibb & Sons, L.L.C.
20250102
HYALURONIDASE (HUMAN RECOMBINANT); NIVOLUMAB
BLA
2000; 120
BLA761381
nivolumab and relatlimab-rmbw
OPDUALAG
0003-7125
E.R. Squibb & Sons, L.L.C.
20220318
NIVOLUMAB; RELATLIMAB
BLA
12; 4
BLA761234
Mycophenolate Mofetil
CellCept
0004-0259
Genentech, Inc.
19950503
MYCOPHENOLATE MOFETIL
NDA
250
NDA050722
Mycophenolate Mofetil
CellCept
0004-0260
Genentech, Inc.
19970619
MYCOPHENOLATE MOFETIL
NDA
500
NDA050723
Mycophenolate Mofetil
CellCept
0004-0261
Genentech, Inc.
19981001
MYCOPHENOLATE MOFETIL
NDA
200
NDA050759
Mycophenolate Mofetil hydrochloride
CellCept
0004-0298
Genentech, Inc.
19980812
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
NDA
500
NDA050758
oseltamivir phosphate
Tamiflu
0004-0800
Genentech, Inc.
19991027
OSELTAMIVIR PHOSPHATE
NDA
75
NDA021087
oseltamivir phosphate
Tamiflu
0004-0801
Genentech, Inc.
19991027
OSELTAMIVIR PHOSPHATE
NDA
45
NDA021087
oseltamivir phosphate
Tamiflu
0004-0802
Genentech, Inc.
19991027
OSELTAMIVIR PHOSPHATE
NDA
30
NDA021087
Oseltamivir Phosphate
Tamiflu
0004-0822
Genentech, Inc.
20110321
OSELTAMIVIR PHOSPHATE
NDA
6
NDA021246
meningococcal group B vaccine
Trumenba
0005-0100
Wyeth Pharmaceutical Division of Wyeth Holdings LLC
20141105
NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN; NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN
BLA
60; 60
BLA125549
Pneumococcal 20-valent Conjugate Vaccine
Prevnar 20
0005-2000
Wyeth Pharmaceutical Division of Wyeth Holdings LLC
20210810
STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN
BLA
2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 4.4; 2.2; 2.2; 2.2
BLA125731
suvorexant
BELSOMRA
0006-0005
Merck Sharp & Dohme LLC
20140829
SUVOREXANT
NDA
5
NDA204569
ivermectin
STROMECTOL
0006-0032
Merck Sharp & Dohme LLC
19961122
IVERMECTIN
NDA
3
NDA050742
suvorexant
BELSOMRA
0006-0033
Merck Sharp & Dohme LLC
20140829
SUVOREXANT
NDA
10
NDA204569
sitagliptin and metformin hydrochloride
JANUMET
0006-0078
Merck Sharp & Dohme LLC
20120202
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
NDA
500; 50
NDA202270
sitagliptin and metformin hydrochloride
JANUMET
0006-0080
Merck Sharp & Dohme LLC
20120202
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
NDA
1000; 50
NDA202270
sitagliptin and metformin hydrochloride
JANUMET
0006-0081
Merck Sharp & Dohme LLC
20120202
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
NDA
1000; 100
NDA202270
sitagliptin
JANUVIA
0006-0112
Merck Sharp & Dohme LLC
20061016
SITAGLIPTIN PHOSPHATE
NDA
50
NDA021995
sitagliptin
JANUVIA
0006-0221
Merck Sharp & Dohme LLC
20061016
SITAGLIPTIN PHOSPHATE
NDA
25
NDA021995
首页
(current)
2
(current)
3
(current)
4
(current)
5
(current)
6
(current)
7
(current)
8
(current)
9
(current)
10
(current)
11
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
医药研究数据
|
医药资料
|
SDA药品评审中心
|
中医网
|
中药处方系统
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:330683240604819103159
医药代理商群1:
医药代理商群2:
医药代理商群3: